33738 Federal Register / Vol. 86, No. 120 / Friday, June 25, 2021 / Notices 

1The record is defined in § 207.2(f) of the 

Commission’s Rules of Practice and Procedure (19 

CFR 207.2(f)). 

certain lithium ion batteries, battery 

cells, battery modules, battery packs, 

components thereof, and processes 

therefor by reason of misappropriation 

of trade secrets, the threat or effect of 

which is to destroy or substantially 

injure an industry in the United States, 

under subsection (a)(1)(A) of section 

337. The complaint, as supplemented, 

names SK Innovation Co., Ltd. of Seoul, 

Republic of Korea and SK Battery 

America, Inc. of Atlanta, Georgia as the 

respondents (collectively, 

‘‘respondents’’ or ‘‘SK’’). The Office of 

Unfair Import Investigations (‘‘OUII’’) 

was also named as a party in this 

investigation. 

On February 14, 2020, the 

administrative law judge issued an 

initial determination (‘‘ID’’) (Order No. 

34) finding that the respondents 

spoliated evidence, and that the 

appropriate remedy is to find the 

respondents in default. 

On April 17, 2020, the Commission 

determined to review the ID in its 

entirety. 85 FR 22,753 (Apr. 23, 2020) 

(‘‘Notice of Review’’). The Notice of 

Review requested that the parties brief 

certain issues and sought briefing from 

the parties, interested government 

agencies, and any other interested 

parties on remedy, the public interest, 

and bonding. 

On February 10, 2021, the 

Commission affirmed the ID’s finding of 

default, thus finding a violation of 

section 337. The Commission issued an 

LEO and two CDOs, all of which were 

tailored to accommodate public interest 

considerations raised by the parties to 

the investigation and by non-parties. 

On May 24, 2021, SK filed a petition 

to rescind the LEO and CDOs on the 

basis of settlement. LG did not oppose 

the petition, and on June 3, 2021, OUII 

filed a response in support of the 

petition. Also, on June 3, 2021, SK filed 

a supplemental submission that 

provided a modified public version of 

the settlement agreement. 

The Commission has determined that 

the petition, as supplemented, complies 

with Commission rules, see 19 CFR 

210.76(a)(3), and that there are no 

extraordinary reasons to deny rescission 

of the remedial orders. Accordingly, the 

Commission has determined to institute 

a rescission proceeding and to 

permanently rescind the LEO and the 

CDOs. The rescission proceeding is 

hereby terminated. 

The Commission’s vote on this 

determination took place on June 21, 

2021. The LEO and CDOs are 

permanently rescinded. 

The authority for the Commission’s 

determination is contained in section 

337 of the Tariff Act of 1930, as 

amended (19 U.S.C. 1337), and in part 

210 of the Commission’s Rules of 

Practice and Procedure (19 CFR part 

210). 

By order of the Commission. 

Issued: June 22, 2021. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2021–13574 Filed 6–24–21; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation Nos. 731–TA–753, 754, and 

756 (Fourth Review)] 

Cut-to-Length Carbon Steel Plate From 

China, Russia, and Ukraine 

Determinations 

On the basis of the record 1 developed 

in the subject five-year reviews, the 

United States International Trade 

Commission (‘‘Commission’’) 

determines, pursuant to the Tariff Act of 

1930 (‘‘the Act’’), that revocation of the 

antidumping duty order on cut-to-length 

carbon steel plate from China and the 

termination of the suspended 

investigations on cut-to-length carbon 

steel plate from Russia and Ukraine 

would be likely to lead to continuation 

or recurrence of material injury to an 

industry in the United States within a 

reasonably foreseeable time. 

Background 

The Commission instituted these 

reviews on November 2, 2020 (85 FR 

69362) and determined on February 5, 

2021 that it would conduct expedited 

reviews (86 FR 26067, May 12, 2021). 

The Commission made these 

determinations pursuant to section 

751(c) of the Act (19 U.S.C. 1675(c)). It 

completed and filed its determinations 

in these reviews on June 21, 2021. The 

views of the Commission are contained 

in USITC Publication 5205 (June 2021), 

entitled Cut-to-Length Carbon Steel 

Plate from China, Russia, and Ukraine: 

Investigation Nos. 731–TA–753, 754, 

and 756 (Fourth Review). 

By order of the Commission. 

Issued: June 21, 2021. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2021–13523 Filed 6–24–21; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. 19–18] 

Robert Wayne Locklear, M.D.; Decision 

and Order 

I. Procedural History 

On March 26, 2019, the Assistant 

Administrator, Diversion Control 

Division, Drug Enforcement 

Administration (hereinafter, DEA or 

Government), issued an Order to Show 

Cause (hereinafter, OSC) to Robert 

Wayne Locklear, M.D., (hereinafter, 

Respondent) of Johnson City, 

Tennessee. Administrative Law Judge 

(hereinafter, ALJ) Exhibit (hereinafter, 

ALJX) 1 (OSC), at 1. The OSC proposed 

the denial of Respondent’s application 

for a DEA Certificate of Registration, 

Application Control No. W18124612C, 

‘‘pursuant to 21 U.S.C. 824(a)(2) & (a)(5), 

because [Respondent has] been 

convicted of a felony related to 

controlled substances and because [he 

has] been excluded from participation 

in a program pursuant to section 1320a– 

7(a) of Title 42.’’ Id. 

Specifically, the OSC alleged that, on 

October 8, 2014, Judgment was entered 

against Respondent in the United States 

District Court for the Eastern District of 

Tennessee (hereinafter, E.D. Tenn.) 

‘‘after [Respondent] pled guilty to: one 

count of ‘Conspiracy to Distribute a 

Quantity of Cocaine Base,’ in violation 

of 21 U.S.C. 846 & 841(b)(1)(C); and one 

count of ‘Conspiracy to Defraud a 

Health Care Benefit Program,’ in 

violation of 18 U.S.C. 1347 & 1349.’’ Id. 

at 2 (citing U.S. v. Robert Wayne 

Locklear, No. 2:14–CR–38 (E.D. Tenn. 

Oct. 8, 2014)). The OSC alleged that 

Respondent’s conviction of a felony 

related to controlled substances 

warrants the denial of Respondent’s 

application pursuant to 21 U.S.C. 

824(a)(2). 

The OSC further alleged that ‘‘based 

on [such] conviction, the U.S. 

Department of Health and Human 

Services, Office of Inspector General 

(‘HHS/OIG’) mandatorily excluded 

[Respondent] from participation in 

Medicare, Medicaid, and all Federal 

health care programs pursuant to 42 

U.S.C. 1320a–7(a).’’ Id. The OSC stated 

that this exclusion took effect on June 

18, 2015, and ‘‘runs for a period of ten 

years,’’ and that such exclusion 

‘‘warrants denial of [Respondent’s] 

application for DEA registration 

pursuant to 21 U.S.C. 824(a)(5).’’ Id. 

The Order to Show Cause notified 

Respondent of the right to request a 

hearing on the allegations or to submit 


lotter on DSK11XQN23PROD with NOTICES1